Efficacy and safety of Buxus sempervirens L. preparations (SPV30) in HIV-infected asymptomatic patients: a multicentre, randomized, double-blind, placebo-controlled trial
- 31 March 1998
- journal article
- Published by Elsevier in Phytomedicine
- Vol. 5 (1) , 1-10
- https://doi.org/10.1016/s0944-7113(98)80052-4
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Spirofornabuxine, a novel type of Buxus alkaloidTetrahedron Letters, 1997
- Changes in Plasma HIV-1 RNA and CD4+ Lymphocyte Counts and the Risk of Progression to AIDSNew England Journal of Medicine, 1996
- Evaluation of proviral copy number and plasma RNA level as early indicators of progression in HIV-1 infectionAIDS, 1994
- N‐Acetylcysteine inhibits apoptosis and decreases viral particles in HIV‐chronically infected U937 cellsFEBS Letters, 1993
- Antioxidant activities of lignans and flavonoidsPhytochemistry, 1990
- Chemical Constituents ofBuxus sempervirensPlanta Medica, 1988
- The antioxidants of higher plantsPhytochemistry, 1988
- Alkaloids of buxus sempervirens L. - VI - structure of buxpsiine.Tetrahedron Letters, 1966
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- On a Test of Whether one of Two Random Variables is Stochastically Larger than the OtherThe Annals of Mathematical Statistics, 1947